Over an 11-day course of treatment, compound 35h showed a dose-dependent inhibition of BaF3-tel-c-KIT-T670I tumor progression with almost 100% tumor growth inhibition at a dosage of 100 mg/kg/day. Here, KIT is linked to neoplasm.